CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 231 filers reported holding CONMED CORP in Q1 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,857,450 | +30.8% | 205,000 | 0.0% | 0.66% | +30.5% |
| Q1 2023 | $21,291,300 | +17.2% | 205,000 | 0.0% | 0.51% | +16.2% |
| Q4 2022 | $18,171,200 | -2.7% | 205,000 | -12.0% | 0.44% | -9.3% |
| Q3 2022 | $18,680,000 | -12.5% | 233,000 | +4.5% | 0.48% | -22.4% |
| Q2 2022 | $21,354,000 | -29.0% | 223,000 | +10.1% | 0.62% | -18.0% |
| Q1 2022 | $30,081,000 | +4.8% | 202,500 | 0.0% | 0.76% | +14.2% |
| Q4 2021 | $28,706,000 | +35.0% | 202,500 | +24.6% | 0.66% | +48.3% |
| Q3 2021 | $21,260,000 | -4.8% | 162,500 | 0.0% | 0.45% | +1.4% |
| Q2 2021 | $22,332,000 | +101.0% | 162,500 | +91.0% | 0.44% | +82.2% |
| Q1 2021 | $11,111,000 | +27.2% | 85,085 | +9.1% | 0.24% | +30.8% |
| Q4 2020 | $8,736,000 | -38.3% | 78,000 | -56.7% | 0.18% | -48.5% |
| Q3 2020 | $14,161,000 | +9.3% | 180,000 | 0.0% | 0.36% | +1.1% |
| Q2 2020 | $12,958,000 | +25.7% | 180,000 | 0.0% | 0.36% | -16.7% |
| Q1 2020 | $10,309,000 | – | 180,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |